QAPRTase Antibodies

Santa Cruz Biotechnology delivers a wide array of QAPRTase monoclonal antibodies for advanced research in biochemistry and molecular biology. QAPRTase monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). QAPRTase, or quinolinate phosphoribosyltransferase, plays a crucial role in the NAD+ biosynthesis pathway, converting quinolinate to nicotinamide adenine dinucleotide (NAD+). QAPRTase is essential for cellular metabolism and energy production, making it a significant target for studies related to neurodegenerative diseases and metabolic disorders. Understanding the function and regulation of QAPRTase can provide insights into therapeutic strategies for conditions associated with NAD+ deficiency. Research focused on QAPRTase has revealed its importance in maintaining cellular NAD+ levels, which are critical for numerous biological processes. Investigating QAPRTase expression patterns and activity helps scientists better understand metabolic regulation and potential therapeutic interventions. QAPRTase research continues to uncover new aspects of NAD+ metabolism and its role in cellular health. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of QAPRTase and its impact on human health.